Cell biology of arterial proteoglycans.
暂无分享,去创建一个
[1] E. Hay,et al. Cell Biology of Extracellular Matrix , 1988, Springer US.
[2] M. Farquhar. The Glomerular Basement Membrane A Selective Macromolecular Filter , 1991 .
[3] L. Sauvage,et al. Endothelial adherence under shear stress is dependent upon microfilament reorganization , 1989, Journal of cellular physiology.
[4] U. Lindahl,et al. Biosynthesis of Heparin and Heparan Sulfate , 1987 .
[5] D. Nochlin,et al. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. , 1988, The American journal of pathology.
[6] T. Wight,et al. Colloidal gold immunostaining on deplasticized ultra-thin sections. , 1988, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[7] M. Lark,et al. Arterial chondroitin sulfate proteoglycan: localization with a monoclonal antibody. , 1988, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[8] P. Carlsson,et al. Identification of Apo B‐100 Segments Mediating the Interaction of Low Density Lipoproteins with Arterial Proteoglycans , 1988, Arteriosclerosis.
[9] P. Segarini,et al. The high molecular weight receptor to transforming growth factor-beta contains glycosaminoglycan chains. , 1988, The Journal of biological chemistry.
[10] R. Mahley,et al. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.
[11] T. Dexter,et al. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis , 1988, Nature.
[12] T. Wight,et al. Structural characterization of heparan sulfate proteoglycan subclasses isolated from bovine aortic endothelial cell cultures. , 1988, Biochemistry.
[13] T. Oegema,et al. Glomerular basement membrane proteoglycans are derived from a large precursor , 1988, The Journal of cell biology.
[14] D. Ingber,et al. A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. , 1988, The American journal of pathology.
[15] M. Bernfield,et al. Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for interstitial matrix , 1988, The Journal of cell biology.
[16] V. Dixit,et al. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation , 1988, The Journal of cell biology.
[17] B. Schick,et al. Sulfated proteoglycans and sulfated proteins in guinea pig megakaryocytes and platelets in vivo. Relevance to megakaryocyte maturation and platelet activation. , 1988, The Journal of biological chemistry.
[18] H. Kresse,et al. Cell-free translation of mRNA encoding an arterial smooth muscle cell proteoglycan core protein. , 1988, European journal of cell biology.
[19] G. Berenson,et al. Composition of proteoglycans from human atherosclerotic lesions. , 1987, Experimental and molecular pathology.
[20] A. Schmidt,et al. Mapping of proteoglycans in human arterial tissue. , 1987, European journal of cell biology.
[21] I. Singer,et al. Extracellular matrix fibers containing fibronectin and basement membrane heparan sulfate proteoglycan coalign with focal contacts and microfilament bundles in stationary fibroblasts. , 1987, Experimental cell research.
[22] R. Perris,et al. Amphibian neural crest cell migration on purified extracellular matrix components: a chondroitin sulfate proteoglycan inhibits locomotion on fibronectin substrates , 1987, The Journal of cell biology.
[23] G. Camejo,et al. Effect of arterial proteoglycans on the interaction of LDL with human monocyte-derived macrophages. , 1987, Atherosclerosis.
[24] D. Mosher,et al. Interactions of thrombospondin with endothelial cells: receptor- mediated binding and degradation , 1987, The Journal of cell biology.
[25] J. Couchman. Heterogeneous distribution of a basement membrane heparan sulfate proteoglycan in rat tissues , 1987, The Journal of cell biology.
[26] T. Imamura,et al. Heparan sulfate and heparin as a potentiator or a suppressor of growth of normal and transformed vascular endothelial cells. , 1987, Experimental cell research.
[27] L. Culp,et al. Fibronectin-mediated adhesion of fibroblasts: inhibition by dermatan sulfate proteoglycan and evidence for a cryptic glycosaminoglycan- binding domain , 1987, The Journal of cell biology.
[28] H. Furthmayr,et al. Aortic endothelial cell proteoheparan sulfate. II. Modulation by extracellular matrix. , 1987, The American journal of pathology.
[29] H. Furthmayr,et al. Aortic endothelial cell proteoheparan sulfate. I. Isolation and characterization of plasmamembrane-associated and extracellular species. , 1987, The American journal of pathology.
[30] W. Mckeehan,et al. Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. Stow,et al. Distinctive populations of basement membrane and cell membrane heparan sulfate proteoglycans are produced by cultured cell lines , 1987, The Journal of cell biology.
[32] E. Hertzberg,et al. Proteoglycans and glycosaminoglycans induce gap junction synthesis and function in primary liver cultures , 1987, The Journal of cell biology.
[33] H. Nader,et al. Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[34] A. Edge,et al. Selective deglycosylation of the heparan sulfate proteoglycan of bovine glomerular basement membrane and identification of the core protein. , 1987, Journal of Biological Chemistry.
[35] W. Wagner,et al. Artery wall derived proteoglycan-plasma lipoprotein interaction: lipoprotein binding properties of extracted proteoglycans. , 1987, Atherosclerosis.
[36] N. Fedarko,et al. Involvement of phosphatidylinositol and insulin in the coordinate regulation of proteoheparan sulfate metabolism and hepatocyte growth. , 1987, The Journal of biological chemistry.
[37] J. Folkman,et al. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[38] A. Schmidt,et al. Proliferation-dependent changes of proteoglycan metabolism in arterial smooth muscle cells. , 1987, Biological chemistry Hoppe-Seyler.
[39] T. Kelly,et al. Adhesion Plaques: Sites of Transmembrane Interaction between the Extracellular Matrix and the Actin Cytoskeleton , 1987, Journal of Cell Science.
[40] R. Spiro,et al. Studies on Macromolecular Components of Human Glomerular Basement Membrane and Alterations in Diabetes: Decreased Levels of Heparan Sulfate Proteoglycan and Laminin , 1987, Diabetes.
[41] M. Merrilees,et al. Stimulation of smooth muscle cell glycosaminoglycan synthesis by cultured endothelial cells is dependent on endothelial cell density. , 1987, Atherosclerosis.
[42] G. Gerwig,et al. The structures of N- and O-glycosidic carbohydrate chains of a chondroitin sulfate proteoglycan isolated from the media of the human aorta. , 1987, Archives of biochemistry and biophysics.
[43] W. Pledger,et al. Platelet‐derived growth factor stimulation of [3H]‐glucosamine incorporation in density‐arrested BALB/c‐3T3 cells , 1987, Journal of cellular physiology.
[44] I. Cohen,et al. Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix , 1987, Journal of cellular physiology.
[45] A. Poole. Proteoglycans, Chondrocalcin, and the Calcification of Cartilage Matrix in Endochondrial Ossification , 1987 .
[46] J. Marcum,et al. Heparan Sulfate Species and Blood Vessel Wall Function , 1987 .
[47] M. Lark,et al. Blood Vessel Proteoglycans , 1987 .
[48] M J Merrilees,et al. Changes in collagen fibril diameters across artery walls including a correlation with glycosaminoglycan content. , 1987, Connective tissue research.
[49] T. Scott-Burden,et al. Disulfide-bonded heparan sulfate proteoglycans associated with the surfaces of cultured bovine vascular endothelial cells. , 1987, European journal of biochemistry.
[50] J. Folkman,et al. Angiogenic factors. , 1987, Science.
[51] M. Greaves,et al. Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment , 1987, Nature.
[52] P. Bornstein,et al. Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[53] T. Wight,et al. Physical properties of chondroitin sulphate/dermatan sulphate proteoglycans from bovine aorta. , 1986, The Biochemical journal.
[54] J. Hollmann,et al. Increased activity of chondroitin sulfate-synthesizing enzymes during proliferation of arterial smooth muscle cells. , 1986, Experimental cell research.
[55] R. Markwald,et al. Conditioning of native substrates by chondroitin sulfate proteoglycans during cardiac mesenchymal cell migration , 1986, The Journal of cell biology.
[56] M. Lark,et al. Modulation of proteoglycan metabolism by aortic smooth muscle cells grown on collagen gels. , 1986, Arteriosclerosis.
[57] M. Lark,et al. The melanoma proteoglycan: restricted expression on microspikes, a specific microdomain of the cell surface , 1986, The Journal of cell biology.
[58] J. Picard,et al. Synthesis of sulfated proteoglycans throughout the cell cycle in smooth muscle cells from pig aorta. , 1986, Experimental cell research.
[59] E. Buddecke,et al. Compartmentation and characterization of different proteoglycans in bovine arterial wall. , 1986, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[60] W D Wagner,et al. Plasma low density lipoprotein accumulation in aortas of hypercholesterolemic swine correlates with modifications in aortic glycosaminoglycan composition. , 1986, Atherosclerosis.
[61] R. Penny,et al. Mast cell granules cause proliferation of human microvascular endothelial cells. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[62] M. Levitt,et al. Isolation and partial characterization of endothelial cell extracellular complexes , 1986, Journal of cellular physiology.
[63] H. Kresse,et al. Comparison of small proteoglycans from skin fibroblasts and vascular smooth-muscle cells. , 1986, The Biochemical journal.
[64] L. Fisher,et al. Comparisons of antibody reactivity and enzyme sensitivity between small proteoglycans from bovine tendon, bone, and cartilage. , 1986, The Journal of biological chemistry.
[65] R. Ross,et al. The biology of platelet-derived growth factor , 1986, Cell.
[66] J. Silbert,et al. Glycosaminoglycan production by bovine aortic endothelial cells cultured in sulfate-depleted medium. , 1986, The Journal of biological chemistry.
[67] A. Linker,et al. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates. , 1986, The Biochemical journal.
[68] W. Wagner,et al. A Proposed Structure of Chondroitin 6‐Sulfate Proteoglycan of Human Normal and Adjacent Atherosclerotic Plaque , 1986, Arteriosclerosis.
[69] D. Atha,et al. Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. , 1986, The Journal of biological chemistry.
[70] G. Berenson,et al. Organization of glycosaminoglycan chains in a chondroitin sulfate-dermatan sulfate proteoglycan from bovine aorta. , 1986, Biochimica et biophysica acta.
[71] L. Robert,et al. Proteoglycans from pig aorta. Comparative study of their interactions with lipoproteins. , 1986, The Biochemical journal.
[72] N. Fedarko,et al. Transport of heparan sulfate into the nuclei of hepatocytes. , 1986, The Journal of biological chemistry.
[73] M. Bernfield,et al. Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet‐derived growth factor , 1986, Journal of Cellular Physiology.
[74] T. Nikkari,et al. Glycosaminoglycans in normal and atherosclerotic human coronary arteries. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[75] L. Rodén,et al. Proteoglycans and hypertension. II. [35S]sulfate incorporation into aorta proteoglycans of spontaneously hypertensive rats. , 1986, Collagen and related research.
[76] T. Wight,et al. Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration , 1986, The Journal of cell biology.
[77] R. Ross. The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.
[78] B. Fanburg,et al. Effects of hypoxia and hyperoxia on proteoglycan production by bovine pulmonary artery endothelial cells , 1986, Journal of cellular physiology.
[79] N. Fedarko,et al. A unique heparan sulfate in the nuclei of hepatocytes: structural changes with the growth state of the cells , 1986, The Journal of cell biology.
[80] J. Silbert,et al. Effects of heparan sulfate removal on attachment and reattachment of fibroblasts and endothelial cells. , 1986, Biochemistry.
[81] V. Hascall,et al. Proteoglycan core protein families. , 1986, Annual review of biochemistry.
[82] M. Lark,et al. Vascular cell proteoglycans: evidence for metabolic modulation. , 1986, Ciba Foundation symposium.
[83] R. Timpl,et al. Structure and function of basement membrane proteoglycans. , 1986, Ciba Foundation symposium.
[84] R. Beyth,et al. Heparan sulphate proteoglycan as mediator of some adhesive responses and cytoskeletal reorganization of cells on fibronectin matrices: independent versus cooperative functions. , 1986, Ciba Foundation symposium.
[85] L. Cöster,et al. The functions of the heparan sulphate proteoglycans. , 1986, Ciba Foundation symposium.
[86] A. Poole,et al. Biological roles of dermatan sulphate proteoglycans. , 1986, Ciba Foundation symposium.
[87] G. Laurie,et al. Biosynthesis and structure of the basement membrane proteoglycan containing heparan sulphate side-chains. , 1986, Ciba Foundation symposium.
[88] S. Srinivasan,et al. Complexes of low-density lipoproteins and arterial proteoglycan aggregates promote cholesteryl ester accumulation in mouse macrophages. , 1985, Biochimica et biophysica acta.
[89] A. Schmidt,et al. High-uptake and low-uptake forms of proteoglycans secreted by arterial smooth muscle cells. , 1985, European journal of biochemistry.
[90] E. Ruoslahti,et al. Extracellular matrices and cell adhesion. , 1985, Arteriosclerosis.
[91] Z. Fuks,et al. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes. , 1985, The Journal of clinical investigation.
[92] H. van den Berghe,et al. Heparan sulfate-chondroitin sulfate hybrid proteoglycan of the cell surface and basement membrane of mouse mammary epithelial cells. , 1985, The Journal of biological chemistry.
[93] J. Kenney,et al. Interaction of endothelial cell growth factor with heparin: characterization by receptor and antibody recognition. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[94] M. Jalkanen,et al. Heparan sulfate proteoglycans from mouse mammary epithelial cells: localization on the cell surface with a monoclonal antibody , 1985, The Journal of cell biology.
[95] P. Bornstein,et al. Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells , 1985, The Journal of cell biology.
[96] D. Heinegård,et al. The core proteins of large and small interstitial proteoglycans from various connective tissues form distinct subgroups. , 1985, The Biochemical journal.
[97] S. Ledbetter,et al. Identification of the precursor protein to basement membrane heparan sulfate proteoglycans. , 1985, The Journal of biological chemistry.
[98] D. Cochran,et al. Effect of heparin on vascular smooth muscle cells. I. Cell metabolism , 1985, Journal of cellular physiology.
[99] B. Caleb,et al. Binding and internalization of heparin by vascular smooth muscle cells , 1985, Journal of cellular physiology.
[100] D. Cochran,et al. Effect of heparin on vascular smooth muscle cells. II. Specific protein synthesis , 1985, Journal of cellular physiology.
[101] C. Minick,et al. Insoluble low-density lipoprotein-proteoglycan complexes enhance cholesteryl ester accumulation in macrophages. , 1985, The American journal of pathology.
[102] Clowes Aw,et al. Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. , 1985, Laboratory investigation; a journal of technical methods and pathology.
[103] M. Alavi,et al. Glycosaminoglycan composition and biosynthesis in the endothelium-covered neointima of de-endothelialized rabbit aorta. , 1985, Experimental and molecular pathology.
[104] D. Hajjar,et al. Altered glycosaminoglycan metabolism in injured arterial wall. , 1985, Experimental and molecular pathology.
[105] M. Vuento,et al. Secondary structure of human plasma fibronectin: conformational change induced by calf alveolar heparan sulfates. , 1985, Biochemistry.
[106] V. Hascall,et al. Effects of monensin on the synthesis, transport, and intracellular degradation of proteoglycans in rat ovarian granulosa cells in culture. , 1985, The Journal of biological chemistry.
[107] J. Stow,et al. Basement membrane heparan sulfate proteoglycans are concentrated in the laminae rarae and in podocytes of the rat renal glomerulus. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[108] R. U. Margolis,et al. Isolation and characterization of the heparan sulfate proteoglycans of brain. Use of affinity chromatography on lipoprotein lipase-agarose. , 1985, The Journal of biological chemistry.
[109] J. Campbell,et al. Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis. , 1985, Experimental and molecular pathology.
[110] G. Camejo,et al. Interaction of low density lipoproteins with arterial proteoglycans. The role of charge and sialic acid content. , 1985, Atherosclerosis.
[111] W. Kisiel,et al. An endothelial cell-dependent pathway of coagulation. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[112] M. Merrilees,et al. Effects of endothelial removal and regeneration on smooth muscle glycosaminoglycan synthesis and growth in rat carotid artery in organ culture. , 1985, Laboratory investigation; a journal of technical methods and pathology.
[113] K. Shimada,et al. Evidence that cell surface heparan sulfate is involved in the high affinity thrombin binding to cultured porcine aortic endothelial cells. , 1985, The Journal of clinical investigation.
[114] R. Rosenberg,et al. An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells , 1985, The Journal of cell biology.
[115] S. Srinivasan,et al. Isolation and characterization of a link protein from bovine aorta proteoglycan aggregate. , 1985, Biochimica et biophysica acta.
[116] L. Orci,et al. Human endothelial cell cultures: Phenotypic modulation by leukocyte interleukins , 1985, Journal of cellular physiology.
[117] D. Metcalfe,et al. Biochemical and microscopic evidence for the internalization and degradation of heparin-containing mast cell granules by bovine endothelial cells. , 1985, Laboratory investigation; a journal of technical methods and pathology.
[118] J. Stow,et al. Heparan sulfate proteoglycans are concentrated on the sinusoidal plasmalemmal domain and in intracellular organelles of hepatocytes , 1985, The Journal of cell biology.
[119] M. Klagsbrun,et al. Heparin affinity of anionic and cationic capillary endothelial cell growth factors: analysis of hypothalamus-derived growth factors and fibroblast growth factors. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[120] P. Bornstein,et al. Heparin regulates the collagen phenotype of vascular smooth muscle cells: induced synthesis of an Mr 60,000 collagen , 1985, The Journal of cell biology.
[121] J. Marcum,et al. Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells. , 1985, Biochemical and biophysical research communications.
[122] W. Wagner,et al. Arterial Dermatan Sulfate Proteoglycan Structure in Pigeons Susceptible to Atherosclerosis , 1985, Arteriosclerosis.
[123] T. Wight. Proteoglycans in pathological conditions: atherosclerosis. , 1985, Federation proceedings.
[124] I. Ronchetti,et al. Elastin-proteoglycans association revealed by cytochemical methods. , 1985, Connective tissue research.
[125] L. Fransson,et al. On the self-affinity of heparan sulfates from quiescent or proliferating normal 3T3 cells and from SV40-transformed cells. , 1985, Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry.
[126] A. Clowes,et al. Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. , 1985, Laboratory investigation; a journal of technical methods and pathology.
[127] M A Levitt,et al. The effect of the extracellular matrix on the detachment of human endothelial cells , 1984, Journal of cellular physiology.
[128] H. Kresse,et al. Biosynthesis of proteodermatan sulfate in cultured human fibroblasts. , 1984, The Journal of biological chemistry.
[129] M. Bienkowski,et al. Kinetics of proteoheparan sulfate synthesis, secretion, endocytosis, and catabolism by a hepatocyte cell line. , 1984, The Journal of biological chemistry.
[130] Z. Fuks,et al. Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase. , 1984, The Journal of clinical investigation.
[131] D. Heinegård,et al. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. , 1984, The Biochemical journal.
[132] D. Gospodarowicz,et al. Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[133] A. Woods,et al. Relationship of heparan sulfate proteoglycans to the cytoskeleton and extracellular matrix of cultured fibroblasts , 1984, The Journal of cell biology.
[134] L. Orci,et al. Leukocyte interleukins induce cultured endothelial cells to produce a highly organized, glycosaminoglycan-rich pericellular matrix , 1984, The Journal of cell biology.
[135] P. Bornstein,et al. Heparin and related glycosaminoglycans modulate the secretory phenotype of vascular smooth muscle cells , 1984, The Journal of cell biology.
[136] C. Gajdusek. Release of endothelial cell‐derived growth factor (ECDGAF) by heparin , 1984, Journal of cellular physiology.
[137] L. Wosu,et al. Interaction of high and low density lipoproteins on glycosaminoglycan secretion by human vascular smooth muscle cells and fibroblasts. , 1984, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire.
[138] S. Srinivasan,et al. Recent advances in molecular pathology. Carbohydrate-protein macromolecules and arterial wall integrity--a role in atherogenesis. , 1984, Experimental and molecular pathology.
[139] H. Shio,et al. Lipoprotein-heparin-fibronectin-denatured collagen complexes enhance cholesteryl ester accumulation in macrophages , 1984, The Journal of cell biology.
[140] L. Cöster,et al. Binding of transferrin to the core protein of fibroblast proteoheparan sulfate. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[141] D. Beeler,et al. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells , 1984, Journal of cellular physiology.
[142] A. Schreiber,et al. Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain. , 1984, Science.
[143] R. Timpl,et al. Structure and interactions of heparan sulfate proteoglycans from a mouse tumor basement membrane. , 1984, European journal of biochemistry.
[144] L. Ehrhart,et al. Modulation of types I and III procollagen synthesis at various stages of arterial smooth muscle cell growth in vitro. , 1984, Experimental cell research.
[145] J. Albers,et al. Metabolism of Low Density Lipoprotein by Bovine Endothelial Cells as a Function of Cell Density , 1984, Arteriosclerosis.
[146] H. Engelberg. Heparin and the atherosclerotic process. , 1984, Pharmacological reviews.
[147] S. Srinivasan,et al. Dynamics of lipoprotein-glycosaminoglycan interactions in the atherosclerotic rabbit aorta in vivo. , 1984, Biochimica et biophysica acta.
[148] M. Alavi,et al. Proteoglycan distribution in rat aortic wall following indwelling catheter injury. , 1984, Atherosclerosis.
[149] A. Schmidt,et al. Characterization of proteoglycans synthesized by cultured arterial smooth muscle cells of the rat. , 1984, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[150] D. Volpin,et al. Elastin fiber-associated glycosaminoglycans in beta-aminopropionitrile-induced lathyrism. , 1984, Experimental and molecular pathology.
[151] J. Folkman,et al. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. , 1984, Science.
[152] A. Clowes,et al. Inhibition of vascular smooth muscle cell migration by heparin‐like glycosaminoglycans , 1984, Journal of cellular physiology.
[153] K. Pietilä,et al. Effect of hypoxia on the synthesis of glycosaminoglycans and collagen by rabbit aortic smooth muscle cells in culture. , 1984, Atherosclerosis.
[154] P. A. Mourão,et al. The binding of human aortic glycosaminoglycans and proteoglycans to plasma low density lipoproteins. , 1984, Atherosclerosis.
[155] Z. Fuks,et al. Interaction of T lymphocytes and macrophages with cultured vascular endothelial cells: Attachment, invasion, and subsequent degradation of the subendothelial extracellular matrix , 1984, Journal of cellular physiology.
[156] J. C. Anderson,et al. Distribution in caesium chloride gradients of proteoglycans secreted by bovine aorta smooth muscle cells and study of their aggregation with hyaluronate and cartilage proteoglycan. , 1984, Biochimica et biophysica acta.
[157] D. Hajjar,et al. Lipoprotein and albumin accumulation in reendothelialized and deendothelialized aorta. , 1984, The American journal of pathology.
[158] L. Kjellén,et al. Cell-Surface Glycosaminoglycans , 1984 .
[159] V. Hascall,et al. Studies on the biosynthesis of cartilage proteoglycan in a model system of cultured chondrocytes from the Swarm rat chondrosarcoma , 1984, Journal of cellular biochemistry.
[160] L. Cöster,et al. Proteoheparan sulfate from human skin fibroblasts. Evidence for self-interaction via the heparan sulfate side chains. , 1983, The Journal of biological chemistry.
[161] M. Romano,et al. Partial structure of the active moiety of a lipoprotein complexing proteoglycan from human aorta. , 1983, Atherosclerosis.
[162] E. Levine,et al. Human endothelial cells: use of heparin in cloning and long-term serial cultivation. , 1983, Science.
[163] D. Alonso,et al. Effect of endothelium on glycosaminoglycan accumulation in injured rabbit aorta. , 1983, The American journal of pathology.
[164] T. Oegema,et al. Heparan sulfate--rich anionic sites in the human glomerular basement membrane. Decreased concentration in congenital nephrotic syndrome. , 1983, The New England journal of medicine.
[165] H. Kleinman,et al. Formation of a supramolecular complex is involved in the reconstitution of basement membrane components. , 1983, Biochemistry.
[166] S. Kobayashi,et al. Isolation and characterization of proteoheparan sulfate synthesized in vitro by rat glomeruli. , 1983, The Journal of biological chemistry.
[167] G. Martin,et al. Reduced synthesis of basement membrane heparan sulfate proteoglycan in streptozotocin-induced diabetic mice. , 1983, The Journal of biological chemistry.
[168] P. Colburn,et al. Antibodies to the heparan sulfate proteoglycans synthesized by endothelial cell cultures. , 1983, Biochimica et biophysica acta.
[169] K. Hedman,et al. Chondroitin sulfate at the plasma membranes of cultured fibroblasts , 1983, The Journal of cell biology.
[170] A. Clarke,et al. The effect of the chain length of heparin on its interaction with lipoprotein lipase. , 1983, Biochimica et biophysica acta.
[171] A. Schor,et al. Synthesis of glycosaminoglycans by cloned bovine endothelial cells cultured on collagen gels. , 1983, European journal of biochemistry.
[172] L. Wosu,et al. Effect of low density lipoprotein on glycosaminoglycan secretion by cultured human smooth muscle cells and fibroblasts. Influence of serum concentration and cell proliferation rate. , 1983, Atherosclerosis.
[173] E. Ruoslahti,et al. Effect of a proteoglycan produced by rat tumor cells on their adhesion to fibronectin-collagen substrata. , 1983, Cancer research.
[174] S. Srinivasan,et al. Hemostatic properties and serum lipoprotein binding of a heparan sulfate proteoglycan from bovine aorta. , 1983, Biochimica et biophysica acta.
[175] A. Otto,et al. Early glycoprotein synthesis is required for the initiation of DNA replication in normal animal cells , 1983 .
[176] C. Bastl,et al. Effect of heparin on the in vivo release and clearance of human platelet factor 4. , 1983, Blood.
[177] Y. Chang,et al. Proteoglycans synthesized by smooth muscle cells derived from monkey (Macaca nemestrina) aorta. , 1983, The Journal of biological chemistry.
[178] Erickson Ca,et al. Substrata formed by combinations of extracellular matrix components alter neural crest cell motility in vitro. , 1983 .
[179] L. Kjellén,et al. Reduced Sulfation of Liver Heparan Sulfate in Experimentally Diabetic Rats , 1983, Diabetes.
[180] A. Cryer,et al. Heparan sulphate and the binding of lipoprotein lipase to porcine thoracic aorta endothelium. , 1983, Biochimica et biophysica acta.
[181] H. Kleinman,et al. Loss of heparan sulfate proteoglycan from glomerular basement membrane of nephrotic rats. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[182] D. Steinberg,et al. Enhanced Macrophage Degradation of Biologically Modified Low Density Lipoprotein , 1983, Arteriosclerosis.
[183] P. Bornstein,et al. Sulfated proteoglycans synthesized by vascular endothelial cells in culture. , 1983, The Journal of biological chemistry.
[184] D. Clemmons,et al. Liberation of immunoreactive somatomedin-C from its binding proteins by proteolytic enzymes and heparin. , 1983, Journal of Clinical Endocrinology and Metabolism.
[185] J. Picard,et al. The structural characterization of proteoglycans of cultured aortic smooth muscle cells and arterial wall of the pig. , 1983, Biochimica et biophysica acta.
[186] V. Hascall,et al. Proteoglycans in primate arteries. III. Characterization of the proteoglycans synthesized by arterial smooth muscle cells in culture , 1983, The Journal of cell biology.
[187] L. Culp,et al. Cell surface heparan sulfate mediates some adhesive responses to glycosaminoglycan-binding matrices, including fibronectin , 1983, The Journal of cell biology.
[188] T. Scott-Burden,et al. Sulphate turnover of surface proteoglycans in cultured rat smooth muscle cells. , 1983, Biochemistry international.
[189] M. Brown,et al. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.
[190] E. Turley,et al. Substrata formed by combinations of extracellular matrix components alter neural crest cell motility in vitro. , 1983, Journal of Cell Science.
[191] T. Deuel,et al. Proteoglycan carrier of human platelet factor 4. Isolation and characterization. , 1982, The Journal of biological chemistry.
[192] D. Beeler,et al. Purification and properties of human platelet heparitinase. , 1982, The Journal of biological chemistry.
[193] M. Karnovsky,et al. Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase. , 1982, The Journal of biological chemistry.
[194] H. C. Robinson,et al. Enzymatic depolymerization of heparin-related polysaccharides. Substrate specificities of mouse mastocytoma and human platelet endo-beta-D-glucuronidases. , 1982, The Journal of biological chemistry.
[195] R. Gerrity,et al. Proteoglycan Distribution in Areas of Differing Permeability to Evans Blue Dye in the Aortas of Young Pigs: An Ultrastructural Study , 1982, Arteriosclerosis.
[196] D. Loskutoff,et al. Cultured bovine endothelial cells produce both urokinase and tissue- type plasminogen activators , 1982, The Journal of cell biology.
[197] S. Srinivasan,et al. Studies of arterial wall glycosaminoglycans and collagen during experimental regression of atherosclerotic lesions in cynomolgus monkeys. , 1982, Laboratory investigation; a journal of technical methods and pathology.
[198] W. Wagner,et al. High molecular weight proteoglycans biosynthesized in culture by pigeon aortas. , 1982, Biochimica et biophysica acta.
[199] R. Klebe,et al. Effect of glycosaminoglycans on fibronectin‐mediated cell attachment , 1982, Journal of cellular physiology.
[200] S. Srinivasan,et al. Lipoprotein-glycosaminoglycan interactions in aortas of rabbits fed atherogenic diets containing different fats. , 1982, Atherosclerosis.
[201] A. Schmidt,et al. Isolation and properties of proteoglycans from bovine aorta. , 1982, European journal of biochemistry.
[202] R. Steinman,et al. Intralysosomal accumulation of polyanions. I. Fusion of pinocytic and phagocytic vacuoles with secondary lysosomes , 1982, The Journal of cell biology.
[203] M. Kielian,et al. Intralysosomal accumulation of polyanions. II. Polyanion internalization and its influence on lysosomal pH and membrane fluidity , 1982, The Journal of cell biology.
[204] W. Owen,et al. Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium. , 1982, The Journal of clinical investigation.
[205] K. Stenn,et al. Aortic endothelial cell migration. I. Matrix requirements and composition. , 1982, The American journal of pathology.
[206] H. Kleinman,et al. Alterations in the Basement Membrane (Heparan Sulfate) Proteoglycan in Diabetic Mice , 1982, Diabetes.
[207] P. Colburn,et al. Anti-clotting activity of endothelial cell cultures and heparan sulfate proteoglycans. , 1982, Biochemical and biophysical research communications.
[208] G. Camejo. The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: its possible role in atherogenesis. , 1982, Advances in lipid research.
[209] R. Rosenberg,et al. Binding of lipoprotein lipase to endothelial cells in culture. , 1981, The Journal of biological chemistry.
[210] C. Villemez,et al. Protein glycosylation is required for the proliferation of mitogen-activated lymphocytes. , 1981, Journal of immunology.
[211] M. Cohen,et al. [(35)S]sulfate incorporation into glomerular basement membrane glycosaminoglycans is decreased in experimental diabetes. , 1981, The Journal of laboratory and clinical medicine.
[212] K. Shimada,et al. Involvement of cell surface heparin sulfate in the binding of lipoprotein lipase to cultured bovine endothelial cells. , 1981, The Journal of clinical investigation.
[213] G. Weissmann,et al. Cartilage proteoglycans inhibit fibronectin-mediated adhesion , 1981, Nature.
[214] T. Deuel,et al. Human platelet-derived growth factor. Purification and resolution into two active protein fractions. , 1981, The Journal of biological chemistry.
[215] W. Wagner,et al. Isolation and preliminary characterization of proteoglycans dissociatively extracted from human aorta. , 1981, The Journal of biological chemistry.
[216] S. Srinivasan,et al. Interaction of serum lipoproteins and a proteoglycan from bovine aorta. , 1981, The Journal of biological chemistry.
[217] L. Cöster,et al. Bovine aortic chondroitin sulphate- and dermatan sulphate-containing proteoglycans. Isolation, fractionation and chemical characterization. , 1981, The Biochemical journal.
[218] R. Rosenberg,et al. Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth , 1981, The Journal of cell biology.
[219] J. Scott,et al. Dermatan sulphate-rich proteoglycan associates with rat tail-tendon collagen at the d band in the gap region. , 1981, The Biochemical journal.
[220] C. Esmon,et al. Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. , 1981, The Journal of biological chemistry.
[221] D. Ausprunk,et al. Proteoglycans in the microvasculature. I. Histochemical localization in microvessels of the rabbit eye. , 1981, The American journal of pathology.
[222] M. Merrilees,et al. Interaction of aortic endothelial and smooth muscle cells in culture. Effect on glycosaminoglycan levels. , 1981, Atherosclerosis.
[223] J. Viikari,et al. Type IIA hyperlipoproteinemic sera decrease the synthesis of hyaluronic acid by cultured human aortic smooth muscle cells. , 1981, Atherosclerosis.
[224] W. Mayhan,et al. Microvascular Alterations Develop in Syrian Hamsters After the Induction of Diabetes Mellitus by Streptozotocin , 1981, Diabetes.
[225] C. Heldin,et al. Characterization of a platelet endoglycosidase degrading heparin-like polysaccharides. , 1980, Biochemistry.
[226] S. Moore,et al. Glycosaminoglycan distribution in rabbit aortic wall following balloon catheter deendothelialization. An ultrastructural study. , 1980, Laboratory investigation; a journal of technical methods and pathology.
[227] J. Folkman,et al. Mast cell heparin stimulates migration of capillary endothelial cells in vitro , 1980, The Journal of experimental medicine.
[228] T. Olivecrona,et al. Interaction of lipoprotein lipase with native and modified heparin-like polysaccharides. , 1980, The Biochemical journal.
[229] M. Farquhar,et al. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion , 1980, The Journal of cell biology.
[230] E. Engvall,et al. Basement membrane glycoprotein laminin binds to heparin , 1980, FEBS letters.
[231] D. Pepper,et al. Binding of platelet factor 4 to cultured human umbilical vein endothelial cells. , 1980, Thrombosis research.
[232] J. Scott,et al. Collagen--proteoglycan interactions. Localization of proteoglycans in tendon by electron microscopy. , 1980, The Biochemical journal.
[233] D. Hajjar,et al. Enhancement of cholesterol and cholesteryl ester accumulation in re-endothelialized aorta. , 1980, The American journal of pathology.
[234] T. Nikkari,et al. Prostaglandins enhance the synthesis of glycosaminoglycans and inhibit the growth of rabbit aortic smooth muscle cells in culture. , 1980, Artery.
[235] T. Wight. Vessel proteoglycans and thrombogenesis. , 1980, Progress in hemostasis and thrombosis.
[236] D. Gospodarowicz,et al. The extracellular matrix and the control of proliferation of vascular endothelial and vascular smooth muscle cells. , 1980, Journal of supramolecular structure.
[237] S. Srinivasan,et al. Proteoglycan synthesis and secretion by bovine aortic tissue in organ culture. , 1980, Artery.
[238] P. Knox,et al. Cell adhesion and proteoglycans. I. The effect of exogenous proteoglycans on the attachment of chick embryo fibroblasts to tissue culture plastic and collagen. , 1979, Journal of cell science.
[239] M. Brown,et al. Degradation of low density lipoprotein . dextran sulfate complexes associated with deposition of cholesteryl esters in mouse macrophages. , 1979, The Journal of biological chemistry.
[240] A. Marcus,et al. Enzymatic conversion of prostaglandin endoperoxide H2 and arachidonic acid to prostacyclin by cultured human endothelial cells. , 1978, The Journal of biological chemistry.
[241] A. Dieffenbacher,et al. Arteriosclerosis , 1925, The Indian Medical Gazette.